NCT06618547View on ClinicalTrials.gov

Effectiveness and Safety of the TENEO 317 Model 2 Excimer Laser to Treat Myopia With or Without Astigmatism by Transepithelial Photorefractive Keratectomy

NANot yet recruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions
Myopia
Interventions
DEVICE

TENEO 317 Model 2 excimer laser

TENEO 317 Model 2 excimer laser by Transepithelial Photorefractive Keratectomy

All Listed Sponsors
lead

Bausch & Lomb Incorporated

INDUSTRY

NCT06618547 - Effectiveness and Safety of the TENEO 317 Model 2 Excimer Laser to Treat Myopia With or Without Astigmatism by Transepithelial Photorefractive Keratectomy | Biotech Hunter | Biotech Hunter